Metformin, glucagon-like peptide-1 (GLP-1), thiazolidinediones and other drugs are currently more popular
Lying down or sitting quietly for 30 to 60 minutes after meals can help prevent nausea from worsening
This is higher than the 6% seen with the 2.4 mg dose
Comparison with Other Therapies Phase 1 trials demonstrated that Retatrutides safety profile was comparable to other GLP-1 receptor agonists, with no unexpected safety signals identified
Median t max,SNAC,day10 ranged from 0.4 to 0.7 h for the eight dosing conditions and appeared to be independent of water volume and post-dose fasting period
Retatrutide Dosing Based on Phase 2 trial protocols and emerging Phase 3 data, Retatrutide dosing follows a structured escalation pattern: Starting dose: 0.5mg to 1mg weekly Escalation: Increase every 4 weeks in increments Intermediate doses: 2mg, 4mg, 8mg Maximum dose: 12mg weekly Time to maximum: Approximately 20-24 weeks The commercial formulation, once approved, will likely include pre-filled injection pens similar to those used for semaglutide and tirzepatide